Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States
In addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior high-quality national estimates of the economic burden of PJI utilize data up to 2009 to project PJI growth in the United States through 2020. N...
Gespeichert in:
| Veröffentlicht in: | The Journal of arthroplasty Jg. 36; H. 5; S. 1484 - 1489.e3 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Elsevier Inc
01.05.2021
|
| Schlagworte: | |
| ISSN: | 0883-5403, 1532-8406, 1532-8406 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | In addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior high-quality national estimates of the economic burden of PJI utilize data up to 2009 to project PJI growth in the United States through 2020. Now in the year 2020, it is appropriate to evaluate these past projections and incorporate the latest available data to better understand the current scale and burden of PJI in the United States.
The Nationwide Inpatient Sample (2002-2017) was used to identify rates and associated inpatient costs for primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) and PJI-related revision TKA and THA. Poisson regression was utilized to model past growth and project future rates and cost of PJI of the hip and knee.
Using the most recent data, the combined annual hospital costs related to PJI of the hip and knee were estimated to be $1.85 billion by 2030. This includes $753.4 million for THA PJI and $1.1 billion for TKA PJI, in that year. Increases in PJI costs are mainly attributable to increases in volume. Although the growth in incidence of primary THA and TKA has slowed in recent years, the incidence of PJI and the cost per case of PJI remained relatively constant from 2002 to 2017.
Understanding the current and potential future financial burden of PJI for surgeons, patients, and healthcare systems is essential. There is an urgent need for efficacious preventive strategies in reducing rates of PJI after THA and TKA. |
|---|---|
| AbstractList | In addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior high-quality national estimates of the economic burden of PJI utilize data up to 2009 to project PJI growth in the United States through 2020. Now in the year 2020, it is appropriate to evaluate these past projections and incorporate the latest available data to better understand the current scale and burden of PJI in the United States.
The Nationwide Inpatient Sample (2002-2017) was used to identify rates and associated inpatient costs for primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) and PJI-related revision TKA and THA. Poisson regression was utilized to model past growth and project future rates and cost of PJI of the hip and knee.
Using the most recent data, the combined annual hospital costs related to PJI of the hip and knee were estimated to be $1.85 billion by 2030. This includes $753.4 million for THA PJI and $1.1 billion for TKA PJI, in that year. Increases in PJI costs are mainly attributable to increases in volume. Although the growth in incidence of primary THA and TKA has slowed in recent years, the incidence of PJI and the cost per case of PJI remained relatively constant from 2002 to 2017.
Understanding the current and potential future financial burden of PJI for surgeons, patients, and healthcare systems is essential. There is an urgent need for efficacious preventive strategies in reducing rates of PJI after THA and TKA. In addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior high-quality national estimates of the economic burden of PJI utilize data up to 2009 to project PJI growth in the United States through 2020. Now in the year 2020, it is appropriate to evaluate these past projections and incorporate the latest available data to better understand the current scale and burden of PJI in the United States.BACKGROUNDIn addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior high-quality national estimates of the economic burden of PJI utilize data up to 2009 to project PJI growth in the United States through 2020. Now in the year 2020, it is appropriate to evaluate these past projections and incorporate the latest available data to better understand the current scale and burden of PJI in the United States.The Nationwide Inpatient Sample (2002-2017) was used to identify rates and associated inpatient costs for primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) and PJI-related revision TKA and THA. Poisson regression was utilized to model past growth and project future rates and cost of PJI of the hip and knee.METHODSThe Nationwide Inpatient Sample (2002-2017) was used to identify rates and associated inpatient costs for primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) and PJI-related revision TKA and THA. Poisson regression was utilized to model past growth and project future rates and cost of PJI of the hip and knee.Using the most recent data, the combined annual hospital costs related to PJI of the hip and knee were estimated to be $1.85 billion by 2030. This includes $753.4 million for THA PJI and $1.1 billion for TKA PJI, in that year. Increases in PJI costs are mainly attributable to increases in volume. Although the growth in incidence of primary THA and TKA has slowed in recent years, the incidence of PJI and the cost per case of PJI remained relatively constant from 2002 to 2017.RESULTSUsing the most recent data, the combined annual hospital costs related to PJI of the hip and knee were estimated to be $1.85 billion by 2030. This includes $753.4 million for THA PJI and $1.1 billion for TKA PJI, in that year. Increases in PJI costs are mainly attributable to increases in volume. Although the growth in incidence of primary THA and TKA has slowed in recent years, the incidence of PJI and the cost per case of PJI remained relatively constant from 2002 to 2017.Understanding the current and potential future financial burden of PJI for surgeons, patients, and healthcare systems is essential. There is an urgent need for efficacious preventive strategies in reducing rates of PJI after THA and TKA.DISCUSSIONUnderstanding the current and potential future financial burden of PJI for surgeons, patients, and healthcare systems is essential. There is an urgent need for efficacious preventive strategies in reducing rates of PJI after THA and TKA. |
| Author | Farley, Kevin X. Sculco, Peter K. Premkumar, Ajay McLawhorn, Alexander S. Kolin, David A. Cross, Michael B. Wilson, Jacob M. |
| Author_xml | – sequence: 1 givenname: Ajay orcidid: 0000-0003-1080-8655 surname: Premkumar fullname: Premkumar, Ajay organization: Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY – sequence: 2 givenname: David A. surname: Kolin fullname: Kolin, David A. organization: Weill Cornell School of Medicine, New York, NY – sequence: 3 givenname: Kevin X. surname: Farley fullname: Farley, Kevin X. organization: Emory University School of Medicine, Atlanta, GA – sequence: 4 givenname: Jacob M. surname: Wilson fullname: Wilson, Jacob M. organization: Department of Orthopaedic Surgery, Emory University, Atlanta, GA – sequence: 5 givenname: Alexander S. surname: McLawhorn fullname: McLawhorn, Alexander S. organization: Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY – sequence: 6 givenname: Michael B. surname: Cross fullname: Cross, Michael B. organization: Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY – sequence: 7 givenname: Peter K. surname: Sculco fullname: Sculco, Peter K. organization: Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33422392$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkE1vEzEQhi1URNPCH-CAfOSyqb93F3GhVaFfUitBz5YzO6s6bOxgO0j99zhN20MP5WTpnfcZeZ4DshdiQEI-cjbnjJuj5dylcjcXTNRAzBnTb8iMaymaTjGzR2as62SjFZP75CDnJWOca63ekX0plRCyFzMy3KS4RCg40FOIIa480ONNGjDQONIbTH6dYi53WOrgIvpQ6HkYK-DjQ6NO6JlfUxcGehkQqQ8P2W3w250_iyuY35O3o5syfnh8D8nt99NfJ2fN1fWP85NvVw2oVpamhc4YwXrskUsG3CnTOiVcv2B6FANo5oAj6E5r1gpXo163BkfeglkYAHlIPu_21j__2WAuduUz4DS5gHGTrVCt6ZTSqqvVT4_VzWKFg10nv3Lp3j6ZqQWxK0C9Pyccnyuc2a1-u7Rb_Xar33Jhq_4KdS8g8NVAdVWS89Pr6NcdilXQX4_JZvAYAAefqm47RP86_uUFDpMPHtz0G-__B_8DsemzGA |
| CitedBy_id | crossref_primary_10_3389_fmed_2024_1397192 crossref_primary_10_25259_JMSR_148_2025 crossref_primary_10_1016_j_arth_2024_03_069 crossref_primary_10_3389_fcimb_2024_1394352 crossref_primary_10_1016_j_arth_2025_05_077 crossref_primary_10_1016_j_arth_2024_10_021 crossref_primary_10_5312_wjo_v14_i8_589 crossref_primary_10_1055_a_2451_8845 crossref_primary_10_1302_2633_1462_66_BJO_2025_0004_R1 crossref_primary_10_1097_CORR_0000000000003561 crossref_primary_10_60118_001c_121295 crossref_primary_10_1016_j_arth_2025_04_036 crossref_primary_10_1111_jcpt_13545 crossref_primary_10_1097_CORR_0000000000002358 crossref_primary_10_1016_j_arth_2024_03_063 crossref_primary_10_3390_biomedicines13081855 crossref_primary_10_1007_s00402_025_05955_0 crossref_primary_10_1177_15563316241230052 crossref_primary_10_2106_JBJS_24_00689 crossref_primary_10_7759_cureus_84055 crossref_primary_10_2106_JBJS_21_00958 crossref_primary_10_1007_s00132_024_04562_y crossref_primary_10_1016_j_arth_2024_03_057 crossref_primary_10_1016_j_arth_2024_03_054 crossref_primary_10_1007_s00402_023_04822_0 crossref_primary_10_1016_j_intimp_2023_110073 crossref_primary_10_1186_s12891_025_08296_6 crossref_primary_10_3390_antibiotics14090900 crossref_primary_10_3390_microorganisms11092296 crossref_primary_10_1016_j_arth_2023_07_018 crossref_primary_10_1016_j_arth_2024_09_022 crossref_primary_10_1056_NEJMoa2301401 crossref_primary_10_1007_s00132_025_04690_z crossref_primary_10_1371_journal_pone_0282662 crossref_primary_10_3390_antibiotics13030198 crossref_primary_10_1016_j_eimce_2025_02_015 crossref_primary_10_1186_s42836_022_00136_5 crossref_primary_10_1016_j_ajoms_2023_08_016 crossref_primary_10_1016_j_arth_2025_05_060 crossref_primary_10_1002_adfm_202409491 crossref_primary_10_1097_CORR_0000000000003457 crossref_primary_10_1016_j_arth_2022_06_018 crossref_primary_10_1089_sur_2023_004 crossref_primary_10_1016_j_idc_2025_02_010 crossref_primary_10_1007_s00339_022_06062_2 crossref_primary_10_1016_j_arth_2023_01_036 crossref_primary_10_1016_j_idc_2025_02_016 crossref_primary_10_2340_17453674_2025_43477 crossref_primary_10_1186_s13018_024_04745_5 crossref_primary_10_4103_tcmj_tcmj_309_23 crossref_primary_10_1016_j_eimc_2025_02_007 crossref_primary_10_3389_fcimb_2021_693939 crossref_primary_10_3390_antibiotics12111629 crossref_primary_10_2106_JBJS_24_01630 crossref_primary_10_2106_JBJS_CC_24_00600 crossref_primary_10_1111_os_14081 crossref_primary_10_1002_prca_202200071 crossref_primary_10_1007_s00590_024_04093_4 crossref_primary_10_1016_j_arth_2024_03_033 crossref_primary_10_1016_j_arth_2025_05_041 crossref_primary_10_1186_s13018_023_04488_9 crossref_primary_10_7759_cureus_53453 crossref_primary_10_1016_j_arth_2024_03_034 crossref_primary_10_1007_s00402_025_06046_w crossref_primary_10_5194_jbji_10_337_2025 crossref_primary_10_1016_j_arth_2022_06_021 crossref_primary_10_1017_ash_2024_57 crossref_primary_10_7759_cureus_83195 crossref_primary_10_1016_j_cmi_2025_02_022 crossref_primary_10_3390_antibiotics11010041 crossref_primary_10_3928_01477447_20210621_07 crossref_primary_10_1016_j_jorep_2025_100683 crossref_primary_10_3389_fcimb_2024_1451398 crossref_primary_10_1186_s12893_024_02631_9 crossref_primary_10_1016_j_arth_2024_02_063 crossref_primary_10_1186_s13018_025_05694_3 crossref_primary_10_1016_j_arth_2023_02_061 crossref_primary_10_1016_j_arth_2024_01_012 crossref_primary_10_1007_s00590_022_03344_6 crossref_primary_10_1007_s00259_023_06146_y crossref_primary_10_1088_1748_605X_adda82 crossref_primary_10_1016_j_arth_2025_06_086 crossref_primary_10_1016_j_artd_2021_11_011 crossref_primary_10_17816_2311_2905_17697 crossref_primary_10_1186_s13018_022_03023_6 crossref_primary_10_3390_microorganisms13040852 crossref_primary_10_1016_j_bios_2023_115120 crossref_primary_10_1016_j_arth_2023_08_015 crossref_primary_10_1177_19386400221136374 crossref_primary_10_3390_jpm12101671 crossref_primary_10_5435_JAAOS_D_25_00458 crossref_primary_10_1001_jamanetworkopen_2024_29702 crossref_primary_10_1007_s00402_025_05934_5 crossref_primary_10_5348_100031Z14MK2025CR crossref_primary_10_2106_JBJS_22_00183 crossref_primary_10_1007_s00064_023_00802_0 crossref_primary_10_1016_j_arth_2024_02_056 crossref_primary_10_1016_j_arth_2025_03_004 crossref_primary_10_1111_iwj_14212 crossref_primary_10_5435_JAAOS_D_23_00120 crossref_primary_10_5371_hp_2025_37_3_197 crossref_primary_10_1016_j_jamda_2024_105269 crossref_primary_10_1007_s00590_023_03557_3 crossref_primary_10_1002_jor_25917 crossref_primary_10_1016_j_ocl_2023_09_001 crossref_primary_10_1016_j_celbio_2025_100131 crossref_primary_10_60118_001c_72787 crossref_primary_10_3390_jcm13010160 crossref_primary_10_7759_cureus_26069 crossref_primary_10_1016_j_arth_2024_02_044 crossref_primary_10_1177_24730114251318735 crossref_primary_10_1186_s10195_025_00833_2 crossref_primary_10_1007_s00402_022_04469_3 crossref_primary_10_7759_cureus_87744 crossref_primary_10_1016_j_jor_2023_10_017 crossref_primary_10_1016_j_arth_2024_01_003 crossref_primary_10_1186_s13018_024_05099_8 crossref_primary_10_3390_ma18010173 crossref_primary_10_17816_2311_2905_17665 crossref_primary_10_1016_j_arth_2022_07_011 crossref_primary_10_1016_j_idcr_2024_e02134 crossref_primary_10_1007_s00264_024_06171_y crossref_primary_10_3390_jfb13030086 crossref_primary_10_1016_j_artd_2025_101694 crossref_primary_10_1016_j_arth_2024_03_070 crossref_primary_10_1016_j_arth_2025_05_080 crossref_primary_10_3390_met14080855 crossref_primary_10_1016_j_arth_2023_06_039 crossref_primary_10_1089_sur_2022_260 crossref_primary_10_1016_j_arth_2021_10_018 crossref_primary_10_1016_j_arth_2025_03_066 crossref_primary_10_1302_2046_3758_137_BJR_2023_0339_R1 crossref_primary_10_1016_j_arth_2023_06_033 crossref_primary_10_1016_j_knee_2024_10_008 crossref_primary_10_1177_23259671231205541 crossref_primary_10_3390_microorganisms12061134 crossref_primary_10_1007_s00402_022_04375_8 crossref_primary_10_1016_j_bioflm_2025_100304 crossref_primary_10_1016_j_arth_2025_09_012 crossref_primary_10_1186_s12984_025_01693_x crossref_primary_10_5435_JAAOS_D_21_00154 crossref_primary_10_1302_0301_620X_107B2_BJJ_2024_0232_R2 crossref_primary_10_1016_j_arth_2025_02_027 crossref_primary_10_3390_app122211518 crossref_primary_10_1016_j_jse_2023_10_029 crossref_primary_10_5435_JAAOS_D_23_01203 crossref_primary_10_5435_JAAOS_D_23_01202 crossref_primary_10_1002_jor_70064 crossref_primary_10_1186_s12877_023_04286_2 crossref_primary_10_3390_medicina60040574 crossref_primary_10_1002_adhm_202501215 crossref_primary_10_1016_j_mcpdig_2025_100230 crossref_primary_10_1097_JS9_0000000000002316 crossref_primary_10_1371_journal_pone_0282709 crossref_primary_10_1007_s15010_024_02285_y crossref_primary_10_1016_j_arth_2023_05_011 crossref_primary_10_1016_j_bioactmat_2022_12_014 crossref_primary_10_7759_cureus_84549 crossref_primary_10_1097_CORR_0000000000002617 crossref_primary_10_2147_IDR_S398958 crossref_primary_10_1007_s00402_024_05315_4 crossref_primary_10_1007_s00264_022_05500_3 crossref_primary_10_1093_cid_ciad360 crossref_primary_10_1186_s10195_025_00844_z crossref_primary_10_1186_s43019_024_00245_2 crossref_primary_10_1002_rcs_2582 crossref_primary_10_5435_JAAOS_D_24_00214 crossref_primary_10_1016_j_jor_2023_03_012 crossref_primary_10_3928_01477447_20221024_06 crossref_primary_10_3390_coatings14020216 crossref_primary_10_1302_2046_3758_1310_BJR_2024_0114_R1 crossref_primary_10_1177_11207000221139467 crossref_primary_10_7717_peerj_18560 crossref_primary_10_1007_s00590_023_03507_z crossref_primary_10_1016_j_arth_2024_01_032 crossref_primary_10_3390_life15040568 crossref_primary_10_2106_JBJS_RVW_22_00201 crossref_primary_10_1016_j_artd_2025_101641 crossref_primary_10_1016_j_artd_2025_101648 crossref_primary_10_1016_j_jconrel_2022_05_021 crossref_primary_10_1016_j_arth_2025_03_057 crossref_primary_10_1016_j_arth_2025_04_084 crossref_primary_10_1016_j_arth_2022_12_010 crossref_primary_10_1089_sur_2023_073 crossref_primary_10_1371_journal_pone_0250910 crossref_primary_10_3389_fsurg_2023_1015490 crossref_primary_10_5435_JAAOS_D_23_00338 crossref_primary_10_1007_s00402_024_05657_z crossref_primary_10_3390_jcm14051531 crossref_primary_10_1016_j_artd_2024_101351 crossref_primary_10_1007_s00402_024_05217_5 crossref_primary_10_1007_s00167_022_06942_3 crossref_primary_10_3389_fresc_2022_824281 crossref_primary_10_3390_ma16217026 crossref_primary_10_1016_j_artd_2023_101175 crossref_primary_10_1016_j_arth_2022_05_034 crossref_primary_10_1016_j_artd_2023_101293 crossref_primary_10_1186_s13018_023_04293_4 crossref_primary_10_5435_JAAOS_D_23_00305 crossref_primary_10_1111_os_13661 crossref_primary_10_1302_0301_620X_105B8_BJJ_2023_0675 crossref_primary_10_1007_s00402_024_05688_6 crossref_primary_10_1089_phage_2024_0001 crossref_primary_10_5435_JAAOSGlobal_D_24_00306 crossref_primary_10_3390_prosthesis5030066 crossref_primary_10_1016_j_ajic_2022_10_016 crossref_primary_10_1016_j_arth_2025_02_072 crossref_primary_10_1007_s00264_023_06066_4 crossref_primary_10_1016_j_arth_2025_02_071 crossref_primary_10_1128_msphere_00583_23 crossref_primary_10_1128_spectrum_00286_25 crossref_primary_10_1016_j_jorep_2025_100656 crossref_primary_10_3390_antibiotics12081229 crossref_primary_10_1002_jor_26029 crossref_primary_10_5435_JAAOS_D_23_00434 crossref_primary_10_1016_j_jcis_2023_01_114 crossref_primary_10_3233_THC_240479 crossref_primary_10_5435_JAAOS_D_23_00317 crossref_primary_10_1016_j_jor_2024_10_053 crossref_primary_10_3390_antibiotics12010054 crossref_primary_10_1177_17585732221081012 crossref_primary_10_1186_s42836_024_00272_0 crossref_primary_10_1186_s12891_024_08080_y crossref_primary_10_1016_j_artd_2025_101633 crossref_primary_10_1016_j_artd_2025_101715 crossref_primary_10_3390_idr14050069 crossref_primary_10_1016_j_arth_2023_08_067 crossref_primary_10_1016_j_jhsa_2024_12_008 crossref_primary_10_3390_jcm14051722 crossref_primary_10_1016_j_arth_2023_12_006 crossref_primary_10_1016_j_artd_2022_04_009 crossref_primary_10_1007_s00402_025_05881_1 crossref_primary_10_1007_s42114_024_01079_y crossref_primary_10_3390_diagnostics12051196 crossref_primary_10_3390_antibiotics11050616 crossref_primary_10_1016_j_arth_2024_09_034 crossref_primary_10_1016_j_artd_2022_05_011 crossref_primary_10_1016_j_diagmicrobio_2022_115804 crossref_primary_10_1016_j_artd_2024_101564 crossref_primary_10_1016_j_ucl_2024_06_002 crossref_primary_10_3389_fbioe_2022_1053399 crossref_primary_10_7759_cureus_46397 crossref_primary_10_2147_ORR_S348919 crossref_primary_10_1088_2516_1091_ad5cb1 crossref_primary_10_1016_j_arth_2024_08_010 crossref_primary_10_1097_BCO_0000000000001324 crossref_primary_10_1111_apm_13490 crossref_primary_10_1055_a_2638_9688 crossref_primary_10_1016_j_arth_2025_01_021 crossref_primary_10_1016_j_ijpharm_2021_121362 crossref_primary_10_2147_IDR_S490962 crossref_primary_10_1080_02656736_2021_2011434 crossref_primary_10_1007_s00264_024_06295_1 crossref_primary_10_1007_s00264_023_05796_9 crossref_primary_10_1016_j_micpath_2025_107497 crossref_primary_10_1016_j_artd_2023_101138 crossref_primary_10_1016_j_snb_2024_136932 crossref_primary_10_1093_cid_ciac694 crossref_primary_10_3390_antibiotics12101490 crossref_primary_10_1016_j_arth_2025_07_001 crossref_primary_10_1016_j_arth_2025_07_003 crossref_primary_10_1016_j_arth_2022_10_013 crossref_primary_10_1016_j_arth_2025_07_007 crossref_primary_10_1016_j_arth_2022_10_014 crossref_primary_10_1016_j_arth_2025_07_008 crossref_primary_10_3390_healthcare12070735 crossref_primary_10_1039_D5RA00367A crossref_primary_10_1016_j_artd_2022_10_011 crossref_primary_10_1016_j_arth_2022_02_027 crossref_primary_10_4055_cios24253 crossref_primary_10_1007_s12028_022_01643_8 crossref_primary_10_1016_j_arth_2024_05_001 crossref_primary_10_5435_JAAOS_D_23_00750 crossref_primary_10_1016_j_arth_2022_09_019 crossref_primary_10_3390_antibiotics12020296 crossref_primary_10_1093_ofid_ofac577 crossref_primary_10_3390_antibiotics14080752 crossref_primary_10_5312_wjo_v16_i7_107575 crossref_primary_10_3390_antibiotics13040306 crossref_primary_10_1016_j_arth_2025_01_044 crossref_primary_10_1016_j_trac_2024_117544 crossref_primary_10_1097_JS9_0000000000001287 crossref_primary_10_52965_001c_138205 crossref_primary_10_1016_j_arth_2024_05_017 crossref_primary_10_1016_j_arth_2021_07_019 crossref_primary_10_1007_s00167_023_07364_5 crossref_primary_10_5435_JAAOS_D_23_00600 crossref_primary_10_3389_fbioe_2025_1593545 crossref_primary_10_1007_s00402_024_05691_x crossref_primary_10_1080_02656736_2022_2065038 crossref_primary_10_1016_j_bioflm_2025_100288 crossref_primary_10_1172_JCI174051 crossref_primary_10_1007_s43465_025_01405_6 crossref_primary_10_60118_001c_89994 crossref_primary_10_1016_j_arth_2023_05_092 crossref_primary_10_1128_aac_00338_25 crossref_primary_10_1007_s00264_025_06501_8 crossref_primary_10_3390_jcm13154467 crossref_primary_10_1016_j_arth_2023_03_010 crossref_primary_10_1016_j_mcna_2024_12_003 crossref_primary_10_2106_JBJS_22_00605 crossref_primary_10_2106_JBJS_23_01118 crossref_primary_10_1016_j_arth_2022_02_034 crossref_primary_10_1055_a_2684_8517 crossref_primary_10_1016_j_arth_2023_04_047 crossref_primary_10_1186_s40634_023_00680_2 crossref_primary_10_1016_j_bioadv_2023_213538 crossref_primary_10_5435_JAAOS_D_24_00290 crossref_primary_10_1302_0301_620X_104B11_BJJ_2022_0944 crossref_primary_10_1016_j_arth_2022_03_072 crossref_primary_10_1038_s41598_025_00760_6 crossref_primary_10_1038_s41598_024_68266_1 crossref_primary_10_1007_s00264_021_05291_z crossref_primary_10_1016_j_arth_2022_03_025 crossref_primary_10_1016_j_arth_2023_05_033 crossref_primary_10_1186_s12891_023_07024_2 crossref_primary_10_3390_ijms241411680 crossref_primary_10_1016_j_arth_2025_08_002 crossref_primary_10_3390_coatings12081125 crossref_primary_10_1002_jor_70034 crossref_primary_10_1007_s00264_025_06636_8 crossref_primary_10_1002_jor_70029 crossref_primary_10_3389_fcimb_2023_1243290 crossref_primary_10_3390_jcm14082610 crossref_primary_10_1002_jor_70024 crossref_primary_10_3389_fbioe_2025_1569211 crossref_primary_10_1016_j_ijantimicag_2023_107080 crossref_primary_10_1093_cid_ciac646 crossref_primary_10_1002_ksa_70056 crossref_primary_10_1186_s13613_024_01370_7 crossref_primary_10_1002_ksa_12182 crossref_primary_10_1002_jor_25696 crossref_primary_10_1089_ten_tea_2021_0081 crossref_primary_10_1016_j_arth_2023_05_025 crossref_primary_10_1093_ofid_ofad224 crossref_primary_10_1016_j_knee_2025_08_001 crossref_primary_10_3390_bioengineering10091018 crossref_primary_10_3390_healthcare12020273 crossref_primary_10_1177_10225536251315973 crossref_primary_10_3390_bioengineering10030356 crossref_primary_10_1016_j_jos_2022_11_014 crossref_primary_10_1016_j_arth_2024_07_035 crossref_primary_10_1016_j_arth_2024_07_034 crossref_primary_10_1016_j_ajic_2023_04_165 crossref_primary_10_3390_v16111800 crossref_primary_10_2106_JBJS_24_01275 crossref_primary_10_3390_ph15020177 crossref_primary_10_7759_cureus_55263 crossref_primary_10_1128_cmr_00104_23 crossref_primary_10_2147_IDR_S489201 crossref_primary_10_3928_01477447_20230310_08 crossref_primary_10_7759_cureus_26864 crossref_primary_10_1002_ksa_70036 crossref_primary_10_1016_j_arth_2024_06_027 crossref_primary_10_1016_j_compositesb_2025_112194 crossref_primary_10_2106_JBJS_RVW_23_00083 crossref_primary_10_1016_j_arth_2024_12_016 crossref_primary_10_1302_0301_620X_107B4_BJJ_2024_1727 crossref_primary_10_1302_0301_620X_107B6_BJJ_2024_0848_R2 crossref_primary_10_1186_s42836_023_00195_2 crossref_primary_10_2106_JBJS_22_00766 crossref_primary_10_1007_s00402_023_05104_5 crossref_primary_10_1007_s11033_025_11046_5 crossref_primary_10_1016_j_arth_2022_02_116 crossref_primary_10_1016_j_otsr_2024_104019 crossref_primary_10_1016_j_arth_2024_05_076 crossref_primary_10_1016_j_arth_2025_05_112 crossref_primary_10_1016_j_arth_2024_12_029 crossref_primary_10_1007_s10544_025_00768_9 crossref_primary_10_1055_a_2559_5268 crossref_primary_10_3390_jcm13020474 crossref_primary_10_1016_j_arth_2025_06_042 crossref_primary_10_1016_j_arth_2023_02_025 crossref_primary_10_1016_j_arth_2025_06_040 crossref_primary_10_1016_j_jse_2025_02_028 crossref_primary_10_1017_ice_2023_253 crossref_primary_10_1016_j_arth_2024_04_033 crossref_primary_10_1016_j_diagmicrobio_2025_116919 crossref_primary_10_3390_microorganisms11071778 crossref_primary_10_1016_j_jare_2025_03_039 crossref_primary_10_1016_j_arth_2025_05_102 crossref_primary_10_1016_j_bjoms_2024_03_003 crossref_primary_10_1177_22925503231161073 crossref_primary_10_5194_jbji_10_165_2025 crossref_primary_10_1055_a_2130_0513 crossref_primary_10_1097_JHQ_0000000000000467 crossref_primary_10_1128_jcm_01126_22 crossref_primary_10_1016_j_arth_2025_06_057 crossref_primary_10_1016_j_jcot_2024_102496 crossref_primary_10_1016_j_arth_2022_01_061 crossref_primary_10_3390_jcm12237277 crossref_primary_10_7759_cureus_70823 crossref_primary_10_1093_ofid_ofaf552 crossref_primary_10_1002_jor_25723 crossref_primary_10_1016_j_arth_2025_06_062 crossref_primary_10_1097_CORR_0000000000002055 crossref_primary_10_3390_antibiotics11020249 crossref_primary_10_1097_CORR_0000000000002291 crossref_primary_10_3390_v13061182 crossref_primary_10_1016_j_arth_2024_04_054 crossref_primary_10_1016_j_arth_2023_03_084 crossref_primary_10_1056_NEJMra2203477 crossref_primary_10_1136_bmjoq_2024_002921 crossref_primary_10_1016_j_arth_2024_04_061 crossref_primary_10_1016_j_jos_2023_07_017 crossref_primary_10_1097_NOR_0000000000001122 crossref_primary_10_1111_os_13278 crossref_primary_10_1016_j_arth_2023_02_059 crossref_primary_10_1016_j_arth_2025_06_076 crossref_primary_10_1007_s00590_025_04438_7 crossref_primary_10_1016_j_arth_2024_04_064 crossref_primary_10_3390_diagnostics15172230 crossref_primary_10_1097_CORR_0000000000003272 crossref_primary_10_1016_j_arth_2024_11_018 crossref_primary_10_1186_s12906_025_04888_w crossref_primary_10_1302_0301_620X_107B4_BJJ_2024_1080 crossref_primary_10_1155_2022_8165580 crossref_primary_10_60118_001c_138887 crossref_primary_10_2106_JBJS_OA_24_00206 crossref_primary_10_55095_achot2024_061 crossref_primary_10_1007_s00402_022_04414_4 crossref_primary_10_1016_j_apsusc_2024_160337 crossref_primary_10_1016_j_artd_2021_08_009 crossref_primary_10_1016_j_jcjp_2023_100107 crossref_primary_10_1007_s40506_024_00274_1 crossref_primary_10_1016_j_recot_2023_02_026 crossref_primary_10_2106_JBJS_CC_21_00393 crossref_primary_10_2340_17453674_2024_41012 crossref_primary_10_1016_j_arth_2024_05_047 crossref_primary_10_1055_a_2288_7187 crossref_primary_10_3389_fbioe_2024_1426388 crossref_primary_10_1016_j_arth_2024_03_010 crossref_primary_10_1016_j_arth_2022_02_050 crossref_primary_10_1016_j_nantod_2024_102334 crossref_primary_10_1016_j_arth_2024_05_048 crossref_primary_10_1093_ofid_ofae159 crossref_primary_10_3390_ijms25010541 crossref_primary_10_1016_j_arth_2023_04_065 crossref_primary_10_3390_jcm14113681 crossref_primary_10_3390_ma16155304 crossref_primary_10_1186_s42836_023_00212_4 crossref_primary_10_3390_microorganisms10081573 crossref_primary_10_1007_s00402_025_05757_4 crossref_primary_10_1111_os_14052 crossref_primary_10_3390_microorganisms13010010 crossref_primary_10_1016_j_bioactmat_2022_02_003 crossref_primary_10_1016_j_saa_2025_126652 crossref_primary_10_1002_jor_25768 crossref_primary_10_3390_antibiotics12061054 crossref_primary_10_1016_j_arth_2024_04_018 crossref_primary_10_1016_j_recot_2023_02_006 crossref_primary_10_1016_j_arth_2023_03_053 crossref_primary_10_1016_j_jinf_2024_106271 crossref_primary_10_1016_j_arth_2023_03_054 crossref_primary_10_5435_JAAOS_D_23_01189 crossref_primary_10_1053_j_sart_2023_01_002 crossref_primary_10_1186_s42836_024_00279_7 crossref_primary_10_1016_j_arth_2022_01_045 crossref_primary_10_3390_diagnostics12071680 crossref_primary_10_1016_j_arth_2025_05_127 crossref_primary_10_1186_s10195_024_00806_x crossref_primary_10_1016_j_arth_2024_10_015 crossref_primary_10_3390_antibiotics13090818 crossref_primary_10_7759_cureus_74049 crossref_primary_10_1002_adhm_202301924 crossref_primary_10_1177_10225536241230349 crossref_primary_10_1021_acsnano_4c17509 |
| Cites_doi | 10.3109/17453674.2011.588859 10.1007/s00264-015-2751-5 10.2106/00004623-200704000-00012 10.1016/j.arth.2012.02.022 10.1016/j.joca.2017.07.022 10.1016/j.arth.2018.02.078 10.1016/j.ijantimicag.2012.10.023 10.1016/j.artd.2017.05.003 10.1007/s11999-013-3316-9 10.1016/j.arth.2018.05.042 10.1007/s11999.0000000000000141 10.1007/s11999-009-0834-6 10.5435/00124635-201012000-00006 10.2106/JBJS.K.00820 10.1007/s12178-012-9139-6 10.2106/JBJS.17.01617 10.2106/JBJS.N.01141 10.1186/1741-7015-10-18 10.1093/cid/cis966 |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier Inc. Copyright © 2020 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2020 Elsevier Inc. – notice: Copyright © 2020 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.arth.2020.12.005 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1532-8406 |
| EndPage | 1489.e3 |
| ExternalDocumentID | 33422392 10_1016_j_arth_2020_12_005 S0883540320312444 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W KOM L7B M29 M41 MO0 N9A O-L O9- OAUVE OF~ OR- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SJN SPCBC SSH SSZ T5K UNMZH UV1 WUQ Z5R ZGI ~G- ~HD AACTN AFCTW RIG 9DU AAYXX CITATION AFKWA AJOXV AMFUW NPM 7X8 |
| ID | FETCH-LOGICAL-c473t-7c866209e9e130c1a467a42a9b05f2dc50ac1ec5855072af2d9576ef17c6b6cc3 |
| ISICitedReferencesCount | 490 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000645124600023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0883-5403 1532-8406 |
| IngestDate | Sun Sep 28 14:36:47 EDT 2025 Wed Feb 19 02:28:32 EST 2025 Sat Nov 29 07:08:44 EST 2025 Tue Nov 18 22:37:09 EST 2025 Sun Apr 06 06:54:05 EDT 2025 Tue Oct 14 19:36:19 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | total hip arthroplasty total knee arthroplasty healthcare cost economic burden prosthetic joint infection |
| Language | English |
| License | Copyright © 2020 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c473t-7c866209e9e130c1a467a42a9b05f2dc50ac1ec5855072af2d9576ef17c6b6cc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-1080-8655 |
| PMID | 33422392 |
| PQID | 2476844548 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2476844548 pubmed_primary_33422392 crossref_primary_10_1016_j_arth_2020_12_005 crossref_citationtrail_10_1016_j_arth_2020_12_005 elsevier_sciencedirect_doi_10_1016_j_arth_2020_12_005 elsevier_clinicalkey_doi_10_1016_j_arth_2020_12_005 |
| PublicationCentury | 2000 |
| PublicationDate | May 2021 2021-05-00 20210501 |
| PublicationDateYYYYMMDD | 2021-05-01 |
| PublicationDate_xml | – month: 05 year: 2021 text: May 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of arthroplasty |
| PublicationTitleAlternate | J Arthroplasty |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Della Valle, Parvizi, Bauer, Dicesare, Evans, Segreti (bib5) 2010; 18 Sloan, Premkumar, Sheth (bib9) 2018; 100 Springer, Cahue, Etkin, Lewallen, McGrory (bib14) 2017; 3 Kurtz, Ong, Lau, Mowat, Halpern (bib19) 2007; 89 Kurtz, Mowat, Ong, Chan, Lau, Halpern (bib20) 2005; 87 Marschall, Lane, Beekmann, Polgreen, Babcock (bib2) 2013; 41 Beswick, Elvers, Smith, Gooberman-Hill, Lovering, Blom (bib3) 2012; 10 Maradit Kremers, Visscher, Kremers, Naessens, Lewallen (bib16) 2014; 472 McFadden (bib13) 1973 Kurtz, Lau, Ong, Zhao, Kelly, Bozic (bib21) 2009; 467 Parvizi, Tan, Goswami, Higuera, Della Valle, Chen (bib6) 2018; 33 Kerkhoffs, Servien, Dunn, Dahm, Bramer, Haverkamp (bib18) 2012; 94 bib11 (bib12) 2017 Osmon, Berbari, Berendt, Lew, Zimmerli, Steckelberg (bib7) 2013; 56 Kurtz, Lau, Watson, Schmier, Parvizi (bib10) 2012; 27 Haverkamp, Klinkenbijl, Somford, Albers, van der Vis (bib17) 2011; 82 Kurtz, Lau, Son, Chang, Zimmerli, Parvizi (bib8) 2018; 33 Shohat, Fleischman, Tarabichi, Tan, Parvizi (bib15) 2018; 476 Bumpass, Nunley (bib1) 2012; 5 Vielgut, Sadoghi, Wolf, Holzer, Leithner, Schwantzer (bib4) 2015; 39 Maradit Kremers, Larson, Crowson, Kremers, Washington, Steiner (bib22) 2015; 97 Inacio, Paxton, Graves, Namba, Nemes (bib23) 2017; 25 Maradit Kremers (10.1016/j.arth.2020.12.005_bib16) 2014; 472 Sloan (10.1016/j.arth.2020.12.005_bib9) 2018; 100 Kurtz (10.1016/j.arth.2020.12.005_bib10) 2012; 27 Kurtz (10.1016/j.arth.2020.12.005_bib8) 2018; 33 Maradit Kremers (10.1016/j.arth.2020.12.005_bib22) 2015; 97 Bumpass (10.1016/j.arth.2020.12.005_bib1) 2012; 5 Parvizi (10.1016/j.arth.2020.12.005_bib6) 2018; 33 Osmon (10.1016/j.arth.2020.12.005_bib7) 2013; 56 Kurtz (10.1016/j.arth.2020.12.005_bib19) 2007; 89 Haverkamp (10.1016/j.arth.2020.12.005_bib17) 2011; 82 Shohat (10.1016/j.arth.2020.12.005_bib15) 2018; 476 Kerkhoffs (10.1016/j.arth.2020.12.005_bib18) 2012; 94 Beswick (10.1016/j.arth.2020.12.005_bib3) 2012; 10 Della Valle (10.1016/j.arth.2020.12.005_bib5) 2010; 18 Marschall (10.1016/j.arth.2020.12.005_bib2) 2013; 41 McFadden (10.1016/j.arth.2020.12.005_bib13) 1973 Kurtz (10.1016/j.arth.2020.12.005_bib21) 2009; 467 Kurtz (10.1016/j.arth.2020.12.005_bib20) 2005; 87 Inacio (10.1016/j.arth.2020.12.005_bib23) 2017; 25 Vielgut (10.1016/j.arth.2020.12.005_bib4) 2015; 39 Springer (10.1016/j.arth.2020.12.005_bib14) 2017; 3 |
| References_xml | – volume: 467 start-page: 2606 year: 2009 end-page: 2612 ident: bib21 article-title: Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030 publication-title: Clin Orthop Relat Res – volume: 472 start-page: 1232 year: 2014 end-page: 1239 ident: bib16 article-title: Obesity increases length of stay and direct medical costs in total hip arthroplasty publication-title: Clin Orthop Relat Res – volume: 18 start-page: 760 year: 2010 end-page: 770 ident: bib5 article-title: Diagnosis of periprosthetic joint infections of the hip and knee publication-title: J Am Acad Orthop Surg – volume: 27 start-page: 61 year: 2012 end-page: 65.e1 ident: bib10 article-title: Economic burden of periprosthetic joint infection in the United States publication-title: J Arthroplasty – volume: 87 start-page: 1487 year: 2005 end-page: 1497 ident: bib20 article-title: Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002 publication-title: J Bone Joint Surg Am – volume: 33 start-page: 1309 year: 2018 end-page: 1314.e2 ident: bib6 article-title: The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria publication-title: J Arthroplasty – volume: 25 start-page: 1797 year: 2017 end-page: 1803 ident: bib23 article-title: Projected increase in total knee arthroplasty in the United States—an alternative projection model publication-title: Osteoarthr Cartil – volume: 5 start-page: 274 year: 2012 end-page: 282 ident: bib1 article-title: Assessing the value of a total joint replacement publication-title: Curr Rev Musculoskelet Med – volume: 97 start-page: 1386 year: 2015 end-page: 1397 ident: bib22 article-title: Prevalence of total hip and knee replacement in the United States publication-title: J Bone Joint Surg Am – volume: 41 start-page: 272 year: 2013 end-page: 277 ident: bib2 article-title: Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey publication-title: Int J Antimicrob Agents – volume: 94 start-page: 1839 year: 2012 end-page: 1844 ident: bib18 article-title: The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review publication-title: J Bone Joint Surg Am – year: 1973 ident: bib13 article-title: Conditional logit analysis of qualitative choice behavior publication-title: Frontiers in econometrics – year: 2017 ident: bib12 article-title: Official web site of the US Health Resources & Services Administration – volume: 476 start-page: 1964 year: 2018 end-page: 1969 ident: bib15 article-title: Weighing in on body mass index and infection after total joint arthroplasty: is there evidence for a body mass index threshold? publication-title: Clin Orthop Relat Res – volume: 56 start-page: 1 year: 2013 end-page: 10 ident: bib7 article-title: Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America publication-title: Clin Infect Dis – volume: 82 start-page: 417 year: 2011 end-page: 422 ident: bib17 article-title: Obesity in total hip arthroplasty—does it really matter? A meta-analysis publication-title: Acta Orthop – volume: 33 start-page: 3238 year: 2018 end-page: 3245 ident: bib8 article-title: Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population publication-title: J Arthroplasty – ident: bib11 article-title: NIS description of data elements n.d. – volume: 89 start-page: 780 year: 2007 end-page: 785 ident: bib19 article-title: Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 publication-title: J Bone Joint Surg Am – volume: 39 start-page: 1731 year: 2015 end-page: 1736 ident: bib4 article-title: Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: when is the best time to perform the second stage? publication-title: Int Orthop – volume: 10 start-page: 18 year: 2012 ident: bib3 article-title: What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients publication-title: BMC Med – volume: 100 start-page: 1455 year: 2018 end-page: 1460 ident: bib9 article-title: Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030 publication-title: J Bone Joint Surg Am – volume: 3 start-page: 137 year: 2017 end-page: 140 ident: bib14 article-title: Infection burden in total hip and knee arthroplasties: an international registry-based perspective publication-title: Arthroplasty Today – volume: 82 start-page: 417 year: 2011 ident: 10.1016/j.arth.2020.12.005_bib17 article-title: Obesity in total hip arthroplasty—does it really matter? A meta-analysis publication-title: Acta Orthop doi: 10.3109/17453674.2011.588859 – volume: 39 start-page: 1731 year: 2015 ident: 10.1016/j.arth.2020.12.005_bib4 article-title: Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: when is the best time to perform the second stage? publication-title: Int Orthop doi: 10.1007/s00264-015-2751-5 – volume: 89 start-page: 780 year: 2007 ident: 10.1016/j.arth.2020.12.005_bib19 article-title: Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 publication-title: J Bone Joint Surg Am doi: 10.2106/00004623-200704000-00012 – volume: 27 start-page: 61 year: 2012 ident: 10.1016/j.arth.2020.12.005_bib10 article-title: Economic burden of periprosthetic joint infection in the United States publication-title: J Arthroplasty doi: 10.1016/j.arth.2012.02.022 – volume: 25 start-page: 1797 year: 2017 ident: 10.1016/j.arth.2020.12.005_bib23 article-title: Projected increase in total knee arthroplasty in the United States—an alternative projection model publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2017.07.022 – volume: 33 start-page: 1309 year: 2018 ident: 10.1016/j.arth.2020.12.005_bib6 article-title: The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria publication-title: J Arthroplasty doi: 10.1016/j.arth.2018.02.078 – year: 1973 ident: 10.1016/j.arth.2020.12.005_bib13 article-title: Conditional logit analysis of qualitative choice behavior – volume: 41 start-page: 272 year: 2013 ident: 10.1016/j.arth.2020.12.005_bib2 article-title: Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2012.10.023 – volume: 3 start-page: 137 year: 2017 ident: 10.1016/j.arth.2020.12.005_bib14 article-title: Infection burden in total hip and knee arthroplasties: an international registry-based perspective publication-title: Arthroplasty Today doi: 10.1016/j.artd.2017.05.003 – volume: 472 start-page: 1232 year: 2014 ident: 10.1016/j.arth.2020.12.005_bib16 article-title: Obesity increases length of stay and direct medical costs in total hip arthroplasty publication-title: Clin Orthop Relat Res doi: 10.1007/s11999-013-3316-9 – volume: 33 start-page: 3238 year: 2018 ident: 10.1016/j.arth.2020.12.005_bib8 article-title: Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population publication-title: J Arthroplasty doi: 10.1016/j.arth.2018.05.042 – volume: 476 start-page: 1964 year: 2018 ident: 10.1016/j.arth.2020.12.005_bib15 article-title: Weighing in on body mass index and infection after total joint arthroplasty: is there evidence for a body mass index threshold? publication-title: Clin Orthop Relat Res doi: 10.1007/s11999.0000000000000141 – volume: 467 start-page: 2606 year: 2009 ident: 10.1016/j.arth.2020.12.005_bib21 article-title: Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030 publication-title: Clin Orthop Relat Res doi: 10.1007/s11999-009-0834-6 – volume: 18 start-page: 760 year: 2010 ident: 10.1016/j.arth.2020.12.005_bib5 article-title: Diagnosis of periprosthetic joint infections of the hip and knee publication-title: J Am Acad Orthop Surg doi: 10.5435/00124635-201012000-00006 – volume: 94 start-page: 1839 year: 2012 ident: 10.1016/j.arth.2020.12.005_bib18 article-title: The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review publication-title: J Bone Joint Surg Am doi: 10.2106/JBJS.K.00820 – volume: 87 start-page: 1487 year: 2005 ident: 10.1016/j.arth.2020.12.005_bib20 article-title: Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002 publication-title: J Bone Joint Surg Am – volume: 5 start-page: 274 year: 2012 ident: 10.1016/j.arth.2020.12.005_bib1 article-title: Assessing the value of a total joint replacement publication-title: Curr Rev Musculoskelet Med doi: 10.1007/s12178-012-9139-6 – volume: 100 start-page: 1455 year: 2018 ident: 10.1016/j.arth.2020.12.005_bib9 article-title: Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030 publication-title: J Bone Joint Surg Am doi: 10.2106/JBJS.17.01617 – volume: 97 start-page: 1386 year: 2015 ident: 10.1016/j.arth.2020.12.005_bib22 article-title: Prevalence of total hip and knee replacement in the United States publication-title: J Bone Joint Surg Am doi: 10.2106/JBJS.N.01141 – volume: 10 start-page: 18 year: 2012 ident: 10.1016/j.arth.2020.12.005_bib3 article-title: What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients publication-title: BMC Med doi: 10.1186/1741-7015-10-18 – volume: 56 start-page: 1 year: 2013 ident: 10.1016/j.arth.2020.12.005_bib7 article-title: Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America publication-title: Clin Infect Dis doi: 10.1093/cid/cis966 |
| SSID | ssj0011554 |
| Score | 2.715905 |
| Snippet | In addition to the significant morbidity and mortality associated with periprosthetic joint infection (PJI), the cost of treating PJI is substantial. Prior... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1484 |
| SubjectTerms | economic burden healthcare cost prosthetic joint infection total hip arthroplasty total knee arthroplasty |
| Title | Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0883540320312444 https://dx.doi.org/10.1016/j.arth.2020.12.005 https://www.ncbi.nlm.nih.gov/pubmed/33422392 https://www.proquest.com/docview/2476844548 |
| Volume | 36 |
| WOSCitedRecordID | wos000645124600023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-8406 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011554 issn: 0883-5403 databaseCode: AIEXJ dateStart: 19951101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpu4e9jI3dskvRYG_Gxpavegyjo0u3ElgHfjOyLLOknRxSt_TP7L_uSLLkZKzdBfYSEtmKDzqfjz5J35EQeguQgNFxw_xW0bck4tSvKW_8phAsr5smI6FOFP6Yn54WZUkXk8l3mwtzfZFLWdzc0PV_dTWUgbNV6uxfuNv9KRTAd3A6fILb4fOPHL8wcytAJG3SsWdyFbTcDSxYq0SPryp50Zt3S9lDjDCCLGkFA8fLtV5UOJFCWCHkDjndprRjcpmmtWCROnkBSHnvZusXG_Ht3Gq5Z6tRt3PSDefFa2m9NwscnJQIwCgKoOeWXumujPtLziGY196nYHvigkSjTNDMptmMmh3BJwQ9LdaItyO02SJlQGK6FW4jsxGq7brhJw1E_MuewUxSrALVCgGYE-pZ4DAd-0GnTvysjFA2EIh4QH-SPXRA8pRC0DyYfTgq526ZSpExM0wxRg9ZWUZA-POTbmM-t41sNMM5e4geDD7EMwOpR2gi5GPUODhhCyds4IS7Fu_CCWs4YQcndQdcwQAnDHDCCk54KXWZgRM2cHqCvrw_Ont37A8nc_g8yePez3mRwVtMBRXAgXjEoLtlCWG0DtOWNDwNGY8ET_VueYRBEYVxrWijnGd1xnn8FO3LTornCGcsE0XcUgbj9iQrChqmgiRNxmDoQVLCpiiyrVbxYdt6dXrKRWX1iatKtXSlWrqKSAUtPUWeq7M2m7bceXdsnVHZdGToQCtAzp21UldrIKuGhP623hvr7woiuVqeY1J0V5cVSdSieJImxRQ9M0Bw1sdxAjyekhf_-NSX6P74Cr5C-_3mSrxG9_h1v7zcHKK9vCwOB3D_AJNwzUE |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Projected+Economic+Burden+of+Periprosthetic+Joint+Infection+of+the+Hip+and+Knee+in+the+United+States&rft.jtitle=The+Journal+of+arthroplasty&rft.au=Premkumar%2C+Ajay&rft.au=Kolin%2C+David+A.&rft.au=Farley%2C+Kevin+X.&rft.au=Wilson%2C+Jacob+M.&rft.date=2021-05-01&rft.pub=Elsevier+Inc&rft.issn=0883-5403&rft.volume=36&rft.issue=5&rft.spage=1484&rft.epage=1489.e3&rft_id=info:doi/10.1016%2Fj.arth.2020.12.005&rft.externalDocID=S0883540320312444 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0883-5403&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0883-5403&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0883-5403&client=summon |